TY  - JOUR

T1  - Re: Erdafitinib in BCG-Treated High-Risk Non-Muscle-Invasive Bladder Cancer

JO  - JOURNAL OF UROLOGY

PY  - 2024/01/01

AU  - Catto JWF

AU  - Tran B

AU  - Roupret M

ED  - 

VL  - 212

IS  - 5

SP  - 779

EP  - 779

Y2  - 2025/04/05

ER  -